Tatva Chintan Pharma Chem Ltd. - Research Center
543321 TATVA Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
P&L
|
| More |
Profit loss account
(Rs crore)
| Mar ' 22 | Mar ' 21 | Mar ' 20 | |||
|---|---|---|---|---|---|
| Income | |||||
| Operating income | 427.81 | 291.19 | 253.84 | ||
| Expenses | |||||
| Material consumed | 209.49 | 151.79 | 135.80 | ||
| Manufacturing expenses | 22.62 | 9.92 | 8.96 | ||
| Personnel expenses | 30.81 | 24.13 | 20.53 | ||
| Selling expenses | - | - | - | ||
| Adminstrative expenses | 59.12 | 40.16 | 36.16 | ||
| Expenses capitalised | - | - | - | ||
| Cost of sales | 322.04 | 226.00 | 201.45 | ||
| Operating profit | 105.77 | 65.19 | 52.39 | ||
| Other recurring income | 10.51 | 5.10 | 0.56 | ||
| Adjusted PBDIT | 116.28 | 70.29 | 52.95 | ||
| Financial expenses | 4.83 | 4.21 | 3.94 | ||
| Depreciation | 8.18 | 6.73 | 4.79 | ||
| Other write offs | - | - | - | ||
| Adjusted PBT | 103.27 | 59.35 | 44.22 | ||
| Tax charges | 7.28 | 7.99 | 9.25 | ||
| Adjusted PAT | 95.99 | 51.36 | 34.96 | ||
| Non recurring items | - | - | - | ||
| Other non cash adjustments | - | - | - | ||
| Reported net profit | 95.99 | 51.36 | 34.96 | ||
| Earnigs before appropriation | 237.88 | 157.97 | 106.61 | ||
| Equity dividend | - | 4.02 | - | ||
| Preference dividend | - | - | - | ||
| Dividend tax | - | - | - | ||
| Retained earnings | 237.88 | 153.95 | 106.61 | ||
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis